Topic intro description here. Limited to 145 characters. Topic intro description here. Limited to 145 characters. Topic intro description here.
In 2022, Executives for Health Innovation (EHI) convened a small group of cybersecurity experts, regulators, and policy experts to discuss cybersecurity concerns facing the healthcare industry.
During this impressive roundtable, the group identified the top concerns driving executives, including:
- new guidance and regulations related to medical devices, healthcare systems, and patient data;
- the current legislative challenges facing Congress; and
- recent FDA draft guidance and pending legislation.
A summary of the key concerns and highlights from the discussion are offered in this report.
EHI thanks Booz Allen Hamilton for their generous support in convening and moderating this roundtable and their continued support of our organization’s work addressing cybersecurity challenges in healthcare.
A recent KFF Health poll found that ~50% of voters are more motivated than ever to vote on Nov. 8 — and 55% of those same voters polled said healthcare issues would be top of mind when it comes time to cast their ballots. Significant changes have happened across the healthcare industry — and regardless of what side of the aisle you find yourself on, we can all agree that the mid-term election results will undoubtedly influence healthcare policy as we know it.
EHI’s Policy Steering Committee members broke down the election results, predicted what’s on deck for Congress in 2023, and reviewed the results’ potential impacts on healthcare policy.
- Jennifer Covich Bordenick, CEO, Executives for Health Innovation
- Julie Clements, JD, MPP, Vice President, External Affairs, UnitedHealth Group
- David Pugach, Vice President, Governmental Affairs and Public Policy, American College of Physicians
EHI’s Policy Steering Committee members will breakdown the election results, predict what’s on deck for Congress in 2023, and review the results’ potential impacts to healthcare policy.
Dr. John Halamka, President of Mayo Clinic Platform, discusses the importance of public/private partnerships inside the healthcare technology ecosystem. He explains how the government can foster, and not stifle, the innovative tools being created to enhance patient care and ensure positive health outcomes through necessary guidelines, guardrails, and the push for transparency of data collection, protection, and clean data-set composition.
Dr. Halamka explains why there is a need to set a standard metrics with which researchers can use to measure the performance of their AI models in healthcare.
- John Halamka, M.D., M.S., President, Mayo Clinic Platform
Dr. John Halamka, President of Mayo Clinic Platform, will discuss the importance of public/private partnerships inside the healthcare technology ecosystem.
The ability to properly exchange and use health information is essential to patient care. It drives improved health outcomes at both the personal and population level.
This isn’t news to the healthcare industry. However, currently, there is no nation-wide standard measurement for interoperability. How can healthcare stakeholders measure their programs and continue to produce positive health outcomes if they can’t quantify this work?
In 2020, the Office of the National Coordinator for Health Information Technology (ONC) created a series of initiatives to pursue a collaborative development of measures that will be valuable to developers, their customers and the general healthcare community. The Interoperability Measurement by Health IT Developers Project, funded by ONC and supported by Clinovations Government + Health and HIMSS, seeks to facilitate discussions with health IT developers and gather insight into five concepts of interest:
- Status of Interoperability Measurement
- Factors That Support Measurement
- Measure Development and Structure
- Customer Implementation and Adoption
- Opportunities for Measures of value
Clinovations Government + Health's CEO, Anita Samarth provides an overview of the Interoperability Measurement by Health IT Developers Project. She dives into the Project’s recent work, reviews major developments, and explains their next steps.
- Anita Samarth, CEO & Co-Founder, Clinovations Government + Health
About the Policy Briefing
Each month, Executives for Health Innovation (EHI) host a monthly policy briefing featuring policymakers, staff, and health policy experts. This is a great opportunity to learn about timely issues and their impact on health IT and digital health. The interactive discussion is held virtually and is a great opportunity to engage directly with experts on policies directly impacting your organization.
The ability to properly exchange and use health information is essential to patient care. However, currently, there is no nation-wide standard measurement for interoperability. How can healthcare stakeholders measure their programs and continue to produce positive health outcomes if they can’t quantify this work?
Federal legislators and regulators are working hard to ensure that all patients have quality healthcare. Often, important decisions about healthcare come down to trust and access to data. It’s no easy task to find a single solution to the myriad of hurdles that payers, providers, and vendors are discovering in their journey to deliver care through the secure sharing of patient data properly. New legislation, such as the No Surprises Act and new regulations, including CMS’s Interoperability Rule, are examples of the federal government working to find the mythical, single solution. However, even the best-written policy can have flaws. Watch EHI’s Policy briefing from Thursday, July 28, 2022, and learn about the challenges healthcare industry leaders have when implementing these policies, and what they suggest can see as the true solution.
The summer (and early fall) of 2022 promises to bring critical milestones for interoperability and data access, tying together many strands linking back to the 2009 HITECH legislation (i.e., Meaningful Use and its successors) and the 2016 21st Century Cures (Cures) legislation. Community participants with an interest in data sharing and interoperability, including those with regulatory compliance responsibilities, will want to track these events very closely.